Partners In Health

Activism delivers unprecedented victories in TB testing and treatment access

Historic price reductions will allow millions more people to receive TB prevention, treatment and testing.

Read More →

Open letter to Johnson & Johnson requesting clarification on the recent deal on generic bedaquiline supply

Advocates call for clarity on the terms of the Johnson & Johnson's deal with the Stop TB Partnership’s Global Drug Facility to supply generic bedaquiline.

Read More →

Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB

Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.

Read More →

Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB

Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.

Read More →

Joint statement on STREAM Stage 1 MDR-TB clinical trial results

Partners In Health (PIH), Interactive Research and Development (IRD) and the Zero TB Initiative (ZTBI) welcome the release of the interim results from the STREAM Stage 1 clinical trial. This is the first clinical trial of a new treatment regimen for multidrug-resistant tuberculosis (MDR-TB), and we congratulate the investigators for successfully conducting it. Unfortunately, we have noticed much confusion about the results of this clinical trial, both in the lay press and in the countries in which we work.

Read More →

Regional capacity-building workshop for TB survivors

The Stop TB Partnership, the Global Coalition of TB Activists (GCTA) and Partners in Health will convene the first Latin American capacity-building workshop for TB survivors on 16-18 August 2017 in Lima, Peru.

Read More →

MDR-TB in North Korea: A Q&A with PIH’s Dr. KJ Seung

For more than a decade, Dr. KJ Seung has been working with Partners In Health to stem the spread of tuberculosis (TB), which kills more than 1 million people every year. From Peru to Lesotho, Seung, 43, has helped design, implement, and scale up programs that deliver effective treatment to patients with hard-to-treat, drug-resistant strains of TB.

Read More →

Page 1 of 1 · Total posts: 7